Prelude Therapeutics Inc
Clinical-stage oncology company developing novel protein degraders and ADCs for cancer.
PRLD | US
Overview
Corporate Details
- ISIN(s):
- US74065P1012
- LEI:
- Country:
- United States of America
- Address:
- 175 INNOVATION BOULEVARD, 19805 WILMINGTON
- Website:
- https://preludetx.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Prelude Therapeutics is a clinical-stage precision oncology company focused on discovering and developing innovative medicines for cancer patients with high unmet medical needs. The company's pipeline features multiple novel drug candidates, including first-in-class, highly selective SMARCA2 and KAT6A protein degraders. Leveraging its expertise in targeted protein degradation, Prelude Therapeutics also develops next-generation degrader antibody conjugates (ADCs) through partnerships. The company employs a science-driven, target-agnostic approach to create therapies that precisely address the drivers of cancer cell growth and mechanisms of resistance, aiming to advance transformational treatments into clinical trials.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Prelude Therapeutics Inc filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Prelude Therapeutics Inc
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Prelude Therapeutics Inc via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
